BioMarin to Attend Upcoming Investor Conference

SAN RAFAEL, Calif., March 6, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Cowen and Company 38^th Annual Health Care Conference on March 13, 2018 at 10:40am ET in Boston.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-attend-upcoming-investor-conference-300608535.html

SOURCE BioMarin Pharmaceutical Inc.